CAZZANIGA, MARINA ELENA
CAZZANIGA, MARINA ELENA
DIPARTIMENTO DI MEDICINA E CHIRURGIA (SCHOOL OF MEDICINE AND SURGERY)
A first-in-human trial on the safety and immunogenicity of COVID-eVax, a cellular response-skewed DNA vaccine against COVID-19
2023 Aurisicchio, L; Brambilla, N; Cazzaniga, M; Bonfanti, P; Milleri, S; Ascierto, P; Capici, S; Vitalini, C; Girolami, F; Giacovelli, G; Caselli, G; Visintin, M; Fanti, F; Ghirri, M; Conforti, A; Compagnone, M; Lione, L; Salvatori, E; Pinto, E; Muzi, A; Marra, E; Palombo, F; Roscilli, G; Manenti, A; Montomoli, E; Cadossi, M; Rovati, L
Detailed stratified GWAS analysis for severe COVID-19 in four European populations
2022 Degenhardt, F; Ellinghaus, D; Juzenas, S; Lerga-Jaso, J; Wendorff, M; Maya-Miles, D; Uellendahl-Werth, F; Elabd, H; Rühlemann, M; Arora, J; Özer, O; Lenning, O; Myhre, R; Vadla, M; Wacker, E; Wienbrandt, L; Ortiz, A; Salazar, A; Chercoles, A; Palom, A; Ruiz, A; Garcia-Fernandez, A; Blanco-Grau, A; Mantovani, A; Zanella, A; Holten, A; Mayer, A; Bandera, A; Cherubini, A; Protti, A; Aghemo, A; Gerussi, A; Ramirez, A; Braun, A; Nebel, A; Barreira, A; Lleo, A; Teles, A; Kildal, A; Biondi, A; Caballero-Garralda, A; Ganna, A; Gori, A; Glück, A; Lind, A; Tanck, A; Hinney, A; Nolla, A; Fracanzani, A; Peschuck, A; Cavallero, A; Dyrhol-Riise, A; Ruello, A; Julià, A; Muscatello, A; Pesenti, A; Voza, A; Rando-Segura, A; Solier, A; Schmidt, A; Cortes, B; Mateos, B; Nafria-Jimenez, B; Schaefer, B; Jensen, B; Bellinghausen, C; Maj, C; Ferrando, C; Horra, C; Quereda, C; Skurk, C; Thibeault, C; Scollo, C; Herr, C; Spinner, C; Gassner, C; Lange, C; Hu, C; Paccapelo, C; Lehmann, C; Angelini, C; Cappadona, C; Azuure, C; Bianco, C; Cea, C; Sancho, C; Hoff, D; Galimberti, D; Prati, D; Haschka, D; Jiménez, D; Pestaña, D; Toapanta, D; Muñiz-Diaz, E; Azzolini, E; Sandoval, E; Binatti, E; Scarpini, E; Helbig, E; Casalone, E; Urrechaga, E; Paraboschi, E; Pontali, E; Reverter, E; Calderón, E; Navas, E; Solligård, E; Contro, E; Arana-Arri, E; Aziz, F; Garcia, F; Sánchez, F; Ceriotti, F; Martinelli-Boneschi, F; Peyvandi, F; Kurth, F; Blasi, F; Malvestiti, F; Medrano, F; Mesonero, F; Rodriguez-Frias, F; Hanses, F; Müller, F; Hemmrich-Stanisak, G; Bellani, G; Grasselli, G; Pezzoli, G; Costantino, G; Albano, G; Cardamone, G; Bellelli, G; Citerio, G; Foti, G; Lamorte, G; Matullo, G; Baselli, G; Kurihara, H; Neb, H; My, I; Kurth, I; Hernández, I; Pink, I; Rojas, I; Galván-Femenia, I; Holter, J; Afset, J; Heyckendorf, J; Kässens, J; Damås, J; Rybniker, J; Altmüller, J; Ampuero, J; Martín, J; Erdmann, J; Banales, J; Badia, J; Dopazo, J; Schneider, J; Bergan, J; Barretina, J; Walter, J; Quero, J; Goikoetxea, J; Delgado, J; Guerrero, J; Fazaal, J; Kraft, J; Schröder, J; Risnes, K; Banasik, K; Müller, K; Gaede, K; Garcia-Etxebarria, K; Tonby, K; Heggelund, L; Izquierdo-Sanchez, L; Bettini, L; Sumoy, L; Sander, L; Lippert, L; Terranova, L; Nkambule, L; Knopp, L; Gustad, L; Garbarino, L; Santoro, L; Téllez, L; Roade, L; Ostadreza, M; Intxausti, M; Kogevinas, M; Riveiro-Barciela, M; Berger, M; Schaefer, M; Niemi, M; Gutiérrez-Stampa, M; Carrabba, M; Figuera Basso, M; Valsecchi, M; Hernandez-Tejero, M; Vehreschild, M; Manunta, M; Acosta-Herrera, M; D'Angiò, M; Baldini, M; Cazzaniga, M; Grimsrud, M; Cornberg, M; Nöthen, M; Marquié, M; Castoldi, M; Cordioli, M; Cecconi, M; D'Amato, M; Augustin, M; Tomasi, M; Boada, M; Dreher, M; Seilmaier, M; Joannidis, M; Wittig, M; Mazzocco, M; Ciccarelli, M; Rodríguez-Gandía, M; Bocciolone, M; Miozzo, M; Ayo, N; Blay, N; Chueca, N; Montano, N; Braun, N; Ludwig, N; Marx, N; Martínez, N; Cornely, O; Witzke, O; Palmieri, O; Faverio, P; Preatoni, P; Bonfanti, P; Omodei, P; Tentorio, P; Castro, P; Rodrigues, P; España, P; Hoffmann, P; Rosenstiel, P; Schommers, P; Suwalski, P; Pablo, R; Ferrer, R; Bals, R; Gualtierotti, R; Gallego-Durán, R; Nieto, R; Carpani, R; Morilla, R; Badalamenti, S; Haider, S; Ciesek, S; May, S; Bombace, S; Marsal, S; Pigazzini, S; Klein, S; Pelusi, S; Wilfling, S; Bosari, S; Volland, S; Brunak, S; Raychaudhuri, S; Schreiber, S; Heilmann-Heimbach, S; Aliberti, S; Ripke, S; Dudman, S; Wesse, T; Zheng, T; Bahmer, T; Eggermann, T; Illig, T; Brenner, T; Pumarola, T; Feldt, T; Folseraas, T; Cejudo, T; Landmesser, U; Protzer, U; Hehr, U; Rimoldi, V; Monzani, V; Skogen, V; Keitel, V; Kopfnagel, V; Friaza, V; Andrade, V; Moreno, V; Albrecht, W; Peter, W; Poller, W; Farre, X; Yi, X; Wang, X; Khodamoradi, Y; Karadeniz, Z; Latiano, A; Goerg, S; Bacher, P; Koehler, P; Tran, F; Zoller, H; Schulte, E; Heidecker, B; Ludwig, K; Fernández, J; Romero-Gómez, M; Albillos, A; Invernizzi, P; Buti, M; Duga, S; Bujanda, L; Hov, J; Lenz, T; Asselta, R; Cid, R; Valenti, L; Karlsen, T; Cáceres, M; Franke, A
Immunomodulatory effects of metronomic vinorelbine (mVRL), with or without metronomic capecitabine (mCAPE), in hormone receptor positive (HR+)/HER2-negative metastatic breast cancer (MBC) patients: final results of the exploratory phase 2 Victor-5 study
2022 Pepe, F; Cazzaniga, M; Baroni, S; Riva, F; Cicchiello, F; Capici, S; Cogliati, V; Maggioni, C; Cordani, N; Cerrito, M; Malandrin, S
How to Treat HR+/HER2-Metastatic Breast Cancer Patients after CDK4/6 Inhibitors: An Unfinished Story
2022 Cogliati, V; Capici, S; Pepe, F; Di Mauro, P; Riva, F; Cicchiello, F; Maggioni, C; Cordani, N; Cerrito, M; Cazzaniga, M
Personalised Therapies for Metastatic Triple-Negative Breast Cancer: When Target Is Not Everything
2022 Capici, S; Ammoni, L; Meli, N; Cogliati, V; Pepe, F; Piazza, F; Cazzaniga, M
The prolonged clinical benefit with metronomic chemotherapy (VEX regimen) in metastatic breast cancer patients
2022 Montagna, E; Pagan, E; Cancello, G; Sangalli, C; Bagnardi, V; Munzone, E; Salè, E; Malengo, D; Cazzaniga, M; Negri, M; Peruzzotti, G; Veronesi, P; Viale, G; Colleoni, M
Metronomic Chemotherapy for Metastatic Breast Cancer Treatment: Clinical and Preclinical Data between Lights and Shadows
2022 Cazzaniga, M; Capici, S; Cordani, N; Cogliati, V; Fulvia Pepe, F; Riva, F; Cerrito, M
Elacestrant (oral selective estrogen receptor degrader) Versus Standard Endocrine Therapy for Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Results From the Randomized Phase III EMERALD Trial
2022 Bidard, F; Kaklamani, V; Neven, P; Streich, G; Montero, A; Forget, F; Mouret-Reynier, M; Sohn, J; Taylor, D; Harnden, K; Khong, H; Kocsis, J; Dalenc, F; Dillon, P; Babu, S; Waters, S; Deleu, I; García Sáenz, J; Bria, E; Cazzaniga, M; Lu, J; Aftimos, P; Cortés, J; Liu, S; Tonini, G; Laurent, D; Habboubi, N; Conlan, M; Bardia, A
Why not? Motivations for entering a volunteer register for clinical trials during the COVID-19 pandemic
2022 Russo, S; Bani, M; Terraneo, M; Quaglia, V; Nuvolati, G; Cavaliere, R; Capici, S; Cazzaniga, M; Strepparava, M
Social capital and willingness to participate in COVID-19 vaccine trials: an Italian case-control study
2022 Terraneo, M; Quaglia, V; Nuvolati, G; Bani, M; Russo, S; Strepparava, M; Capici, S; Cavaliere, R; Cazzaniga, M
Co-targeting triple-negative breast cancer cells and endothelial cells by metronomic chemotherapy inhibits cell regrowth and migration via downregulation of the FAK/VEGFR2/VEGF axis and autophagy/apoptosis activation
2022 Scagliotti, A; Capizzi, L; Cazzaniga, M; Ilari, A; De Giorgi, M; Cordani, N; Gallazzi, M; Bruno, A; Pelosi, G; Albini, A; Lavitrano, M; Grassilli, E; Cerrito, M
Fulvestrant and trastuzumab in patients with luminal HER2-positive advanced breast cancer (ABC): an Italian real-world experience (HERMIONE 9)
2021 Torrisi, R; Palumbo, R; De Sanctis, R; Vici, P; Bianchi, G; Cortesi, L; Leonardi, V; Gueli, R; Fabi, A; Valerio, M; Gambaro, A; Tagliaferri, B; Pizzuti, L; Cazzaniga, M; Santoro, A
The role for tocilizumab in covid-19 patients: Reflections on monza cohort data
2021 Capici, S; Sala, L; Galimberti, S; Valsecchi, M; Squillace, N; Gustinetti, G; Cazzaniga, M; Bonfanti, P
Comparison of tumor microenvironment in primary and paired metastatic ER+/HER2- breast cancers: results of a pilot study
2021 Zeppellini, A; Galimberti, S; Leone, B; Pacifico, C; Riva, F; Cicchiello, F; Capici, S; Maggioni, C; Sala, L; Cazzaniga, M
Managing Menopausal Symptoms in Young Women With Breast Cancer: When Medicine Is Not All. The Take Care Project
2021 Cazzaniga, M; Giordano, M; Bandera, M; Cassani, C; Bounous, V; Lania, A; Biasi, G; Destro, M; Ricci, S; Lucini, D; Biglia, N; Pagani, O
The prognostic relevance of HER2-positivity gain in metastatic breast cancer in the ChangeHER trial
2021 Pizzuti, L; Barba, M; Mazzotta, M; Krasniqi, E; Maugeri-Sacca, M; Gamucci, T; Berardi, R; Livi, L; Ficorella, C; Natoli, C; Cortesi, E; Generali, D; La Verde, N; Cassano, A; Bria, E; Moscetti, L; Michelotti, A; Adamo, V; Zamagni, C; Tonini, G; Sergi, D; Marinelli, D; Paoletti, G; Tomao, S; Botticelli, A; Marchetti, P; Tinari, N; Grassadonia, A; Valerio, M; Mirabelli, R; Fabbri, M; D'Ostilio, N; Veltri, E; Corsi, D; Garrone, O; Paris, I; Sarobba, G; Meattini, I; Pistelli, M; Giotta, F; Lorusso, V; Garufi, C; Russo, A; Cazzaniga, M; Del Medico, P; Roselli, M; Vaccaro, A; Perracchio, L; di Benedetto, A; Daralioti, T; Sperduti, I; De Maria, R; Di Leo, A; Sanguineti, G; Ciliberto, G; Vici, P
Metronomic chemotherapy (mCHT) in metastatic triple-negative breast cancer (TNBC) patients: results of the VICTOR-6 study
2021 Cazzaniga, M; Vallini, I; Montagna, E; Amoroso, D; Berardi, R; Butera, A; Cagossi, K; Cavanna, L; Ciccarese, M; Cinieri, S; Cretella, E; De Conciliis, E; Febbraro, A; Ferrau, F; Ferzi, A; Baldelli, A; Fontana, A; Gambaro, A; Garrone, O; Gebbia, V; Generali, D; Gianni, L; Giovanardi, F; Grassadonia, A; Leonardi, V; Marchetti, P; Sarti, S; Musolino, A; Nicolini, M; Putzu, C; Riccardi, F; Santini, D; Saracchini, S; Sarobba, M; Schintu, M; Scognamiglio, G; Spadaro, P; Taverniti, C; Toniolo, D; Tralongo, P; Turletti, A; Valenza, R; Valerio, M; Vici, P; Di Mauro, P; Cogliati, V; Capici, S; Clivio, L; Torri, V
Methotrexate inhibits SARS-CoV-2 virus replication "in vitro"
2021 Caruso, A; Caccuri, F; Bugatti, A; Zani, A; Vanoni, M; Bonfanti, P; Cazzaniga, M; Perno, C; Messa, C; Alberghina, L
Validation of the Italian version of the full and abbreviated Trust in Oncologist Scale
2021 Bani, M; Rossi, E; Cortinovis, D; Russo, S; Gallina, F; Hillen, M; Canova, S; Cicchiello, F; Longarini, R; Cazzaniga, M; Bidoli, P; Valsecchi, M; Strepparava, M
Oxaliplatin plus fluoropyrimidines as adjuvant therapy for colon cancer in older patients: A subgroup analysis from the TOSCA trial
2021 Rosati, G; Lonardi, S; Galli, F; Di Bartolomeo, M; Ronzoni, M; Zampino, M; Banzi, M; Zaniboni, A; Pasini, F; Bozzarelli, S; Garattini, S; Ferrari, D; Montesarchio, V; Mambrini, A; Ciuffreda, L; Galli, F; Pusceddu, V; Carlomagno, C; Bidoli, P; Amoroso, D; Bochicchio, A; Frassineti, L; Corsi, D; Bilancia, D; Pastorino, A; De Stefano, A; Labianca, R; Bilancia, D; Rosati, G; Montesarchio, V; Iaffaioli, R; Nasti, G; Daniele, B; Zagonel, V; Pella, N; Aprile, G; Pasini, F; Marchetti, R; Romiti, A; Ferrari, D; Foa, P; Zaniboni, A; Mosconi, S; Sobrero, A; Bidoli, P; Cazzaniga, M; Beretta, G; Cortesi, E; Barni, S; Petrelli, F; Allione, P; D'Arco, A; Valmadre, G; Piazza, E; Veltri, E; Ramus, G; Giustini, L; Tumulo, S; Cascinu, S; Granetto, C; Testore, F; Giordano, M; Moroni, M; Di Seri, M; Nuzzo, A; Angelelli, L; Gori, S; Farina, G; Aglietta, M; Franchi, R; Comande, M; Giordani, P; Tonini, G; Bucci, E; Ballestrero, A; Benasso, M; Graiff, C; Bravi, S; Caffo, O; Silva, R; Frontini, L; Rota, S; Cozzi, L; Cantore, M; Maiello, E; Cinieri, S; Silvestris, N; Romito, S; Gebbia, V; Banzi, M; Santoro, A; Artioli, F; Mattioli, R; Contu, A; Di Costanzo, F; Leonardi, F; Cavanna, L; Passalacqua, R; Amoroso, D; Sozzi, P; D'Amico, M; Amadori, D; Frassineti, L; Turci, D; Ravaioli, A; Pasquini, E; Gambi, A; Faedi, M; Cruciani, G; Bajetta, E; Di Bartolomeo, M; Gianni, L; Ionta, M; Massidda, B; Scartozzi, M; Zampino, M; Bochicchio, A; Ciarlo, A; Di Leo, A; Frustaci, S; Rangoni, G; Arizzoia, A; Pavesi, L; Verusio, C; Pinotti, G; Iop, A; De Placido, S; Carlomagno, C; Adamo, V; Ficorella, C; Natale, D; Greco, E; Rulli, E; Galli, F; Poli, D; Porcu, L; Torri, V